https://saolrx.com/saol-therapeutics-enhances-its-ip-portfolio-for-dichloroacetate-dca-sl-1009-in-glioblastoma-and-rare-pediatric-cancers/
By signing an agreement with Medosome Biotec By providing support for clinical trial treatment of GBM at the University of Florida By starting a collaborative...
ip portfoliosaoltherapeuticsdichloroacetatedca